Literature DB >> 7740421

Surgical sepsis: constancy of antibiotic susceptibility of causative organisms.

C J Krepel1, C M Gohr, C E Edmiston, R E Condon.   

Abstract

BACKGROUND: It is well documented that antibiotic therapy exerts selective pressure on bacteria. Conversion of bacteria from susceptible to resistant to antibiotics has been observed often during antimicrobial therapy. It has been postulated that human intestinal reservoirs facilitate communication of transposons that can transfer resistance determinants among various bacterial species.
METHODS: This study examined the susceptibilities of organisms isolated from infected abdomens to a number of antibiotic agents during a 12-year time interval. Analysis included 1102 isolates recovered from 255 specimens, representing the following genera: Bacteroides, Clostridium, Gemella, Fusobacterium, Peptostreptococcus, Porphyromonas, Prevotella, Enterococcus, Staphylococcus, Streptococcus, Pseudomonas, and Enterobacteriaceae. Strains were tested against beta-lactam agents, beta-lactams in combination with beta-lactamase inhibitors, first, second, and third generation cephalosporins, aminoglycosides, clindamycin, metronidazole, chloramphenicol, and imipenem.
RESULTS: The results indicated that during a time period of more than a decade essentially no change occurred in the antibiotic susceptible fraction of all species tested.
CONCLUSIONS: Abdominal sepsis is caused by leakage of endogenous intestinal flora. This study suggests that the intestinal flora is not permanently affected by short-term antibiotic therapy and that older antibiotics are appropriate first-line therapeutic agents for community-acquired infections caused by normal intestinal flora.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740421     DOI: 10.1016/s0039-6060(05)80249-1

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

Review 1.  [Antimicrobial and antimycotic therapy of intra-abdominal infections].

Authors:  P Kujath; M Hoffmann; A Rodloff
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

Review 2.  Management of secondary peritonitis.

Authors:  D H Wittmann; M Schein; R E Condon
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

3.  Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on susceptibility of Escherichia coli to amoxicillin-clavulanate (Augmentin).

Authors:  I Simpson; J Durodie; S Knott; B Shea; J Wilson; K Machka
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker.

Authors:  Fang Li; Liuyiqi Jiang; Shuming Pan; Shaowei Jiang; Yiwen Fan; Chao Jiang; Chengjin Gao; Yuxin Leng
Journal:  mSystems       Date:  2022-05-16       Impact factor: 7.324

Review 5.  Current concepts in peritonitis.

Authors:  Mark A Malangoni
Journal:  Curr Gastroenterol Rep       Date:  2003-08

6.  Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia.

Authors:  Katie L Burnham; Emma E Davenport; Jayachandran Radhakrishnan; Peter Humburg; Anthony C Gordon; Paula Hutton; Eduardo Svoren-Jabalera; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

7.  Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.

Authors:  Christian Eckmann; M Dryden; P Montravers; R Kozlov; G Sganga
Journal:  Eur J Med Res       Date:  2011-03-28       Impact factor: 2.175

8.  [Characterization of bacterial flora in community peritonitis carried out in Burkina Faso].

Authors:  Mahamoudou Sanou; Armand Ky; Edgard Ouangre; Cyrille Bisseye; Adama Sanou; Bolni Marius Nagalo; Drissa Sanou; Jacques Simporé; Lassana Sangare; Rasmata Traore
Journal:  Pan Afr Med J       Date:  2014-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.